Stay updated with breaking news from Small Molecules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
![MyJournals.org - Science - '[ASAP] Enhanced ASO-Mediated Gene Silencing with Lipophilic pH-Responsive Micelles' (Bioconjugate Chemistry) - Vimarsana News](https://vimarsana.com/images/vimarsana-bigimage.jpg)
MyJournals.org - Science - '[ASAP] Enhanced ASO-Mediated Gene Silencing with Lipophilic pH-Responsive Micelles' (Bioconjugate Chemistry)
An atlas that catalogs gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer, according to researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Lonza (SIX: LONN) today announced a strategic collaboration to support the manufacture of Vertex’s portfolio of investigational stem cell-derived, fully differentiated insulin-producing islet cell therapies for people with T1D, currently focusing on the VX-880 ...
- Following positive Phase 1/2 results in Vertex’s VX-880 program, Vertex and Lonza announce strategic manufacturing collaboration - - Dedicated large-scale facility will support commercial production of Vertex’s T1D cell therapy portfolio - - Approximately 300 new jobs anticipated at Lonza Portsmouth, New Hampshire Site -
Lonza Group AG (OTCMKTS:LZAGY – Get Rating) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $66.00 and last traded at $65.55, with a volume of 135655 shares. The stock had previously closed at $63.45. Wall Street Analysts Forecast Growth Several analysts recently issued reports on LZAGY […]